Efficacy and safety of telaprevir-based treatment for elderly patients with genotype 1 chronic hepatitis C

被引:0
|
作者
Furusyo, N. [1 ]
Murata, M. [1 ]
Ogawa, E. [1 ]
Nomura, H. [2 ]
Hayashi, J. [1 ]
机构
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 812, Japan
[2] Shin Kokura Hosp, Ctr Liver Dis, Kitakyushu, Fukuoka, Japan
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S130 / S130
页数:1
相关论文
共 50 条
  • [41] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [42] Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study
    Luisa Montes, Maria
    Nelson, Mark
    Girard, Pierre-Marie
    Sasadeusz, Joe
    Horban, Andrzej
    Grinsztejn, Beatriz
    Zakharova, Natalia
    Rivero, Antonio
    Durant, Jacques
    Ortega-Gonzalez, Enrique
    Lathouwers, Erkki
    Janssen, Katrien
    Ouwerkerk-Mahadevan, Sivi
    Witek, James
    Gonzalez-Garcia, Juan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 244 - 250
  • [43] Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study
    Roberts, Stuart
    Pol, Stanislas
    Andreone, Pietro
    Younossi, Zobair
    Diago, Moises
    Lawitz, Eric J.
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    Demasi, Ralph
    Heeswijk, Rolf V.
    Meyer, Sandra D.
    Picchio, Gaston
    Witek, James
    Zeuzem, Stefan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 177 - 177
  • [44] Telaprevir-based and simeprevir-based interferon triple therapy for patients with hepatitis C
    Sasaki, Masato
    Tanaka, Hideki
    Takeguchi, Masataka
    Mochinaga, Takaho
    Matsushita, Hiroshi
    Kurano, Soutaro
    Nakamura, Aiko
    Yoshida, Kenichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 382 - 382
  • [45] Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
    Kohjima, Motoyuki
    Kurokawa, Miho
    Enjoji, Munechika
    Yoshimoto, Tsuyoshi
    Nakamura, Tsukasa
    Ohashi, Tomoko
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Murata, Yusuke
    Matsunaga, Kazuhisa
    Kato, Masaki
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1781 - 1787
  • [46] Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
    Kondo, C.
    Atsukawa, M.
    Tsubota, A.
    Shimada, N.
    Abe, H.
    Aizawa, Y.
    JOURNAL OF POSTGRADUATE MEDICINE, 2016, 62 (01) : 20 - 25
  • [47] Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response
    Furusyo, Norihiro
    Ogawa, Eiichi
    Murata, Masayuki
    Toyoda, Kazuhiro
    Ohnishi, Hachiro
    Eiraku, Kunimitsu
    Shimizu, Motohiro
    Harada, Yuji
    Mitsumoto, Fujiko
    Takayama, Koji
    Kainuma, Mosaburo
    Okada, Kyoko
    Hayashi, Jun
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 483 - 490
  • [48] α-Fetoprotein Is a Surrogate Marker for Predicting Treatment Failure in Telaprevir-Based Triple Combination Therapy for Genotype 1b Chronic Hepatitis C Japanese Patients With the IL28B Minor Genotype
    Shimada, Noritomo
    Tsubota, Akihito
    Atsukawa, Masanori
    Abe, Hiroshi
    Ika, Makiko
    Kato, Keizo
    Sato, Yoshiyuki
    Kondo, Chisa
    Sakamoto, Choitsu
    Tanaka, Yasuhito
    Aizawa, Yoshio
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (03) : 461 - 472
  • [49] BOCEPREVIR AND TELAPREVIR EFFECTIVENESS AND SAFETY IN A BRAZILIAN COHORT OF CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS: A MULTICENTRIC LONGITUDINAL STUDY
    Borba, H. H.
    Wiens, A.
    Steimbach, L. M.
    Tonin, F. S.
    Pedroso, M. L.
    Minowa, E.
    Piedade, A.
    Clark, O.
    Fernandez-Llimos, F.
    Pontarolo, R.
    VALUE IN HEALTH, 2017, 20 (09) : A882 - A882
  • [50] Expert Opinion on Boceprevir- and Telaprevir-Based Triple Therapies of Chronic Hepatitis C
    Sarrazin, C.
    Berg, T.
    Cornberg, M.
    Dollinger, M.
    Ferenci, P.
    Hinrichsen, H.
    Klinker, H.
    Kraus, M.
    Manns, M.
    Mauss, S.
    Peck-Radosavljevic, M.
    Schmidt, H.
    Spengler, U.
    Wedemeyer, H.
    Wirth, S.
    Zeuzem, S.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (01): : 57 - 72